For generic drugs, Teva includes future launches in its guidance on a probability-weighted basis unless a product has has a certain launch date stemming from a patent expiration or a legal settlement with the branded-drug company.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.